Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven
1Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia (IIT), Milan, Italy.
Abstract:
Inhibition of bromodomain and extraterminal motif (BET) proteins such as BRD4 bears great promise for cancer treatment and its efficacy has been frequently attributed to Myc downregulation. Here, we use B-cell tumors as a model to address the mechanism of action of JQ1, a widely used BET inhibitor. Although JQ1 led to widespread eviction of BRD4 from chromatin, its effect on gene transcription was limited to a restricted set of genes. This was unlinked to Myc downregulation or its chromatin association. Yet, JQ1-sensitive genes were enriched for Myc and E2F targets, were expressed at high levels, and showed high promoter occupancy by RNAPol2, BRD4, Myc and E2F. Their marked decrease in transcriptional elongation upon JQ1 treatment, indicated that BRD4-dependent promoter clearance was rate limiting for transcription. At JQ1-insensitive genes the drop in transcriptional elongation still occurred, but was compensated by enhanced RNAPol2 recruitment. Similar results were obtained with other inhibitors of transcriptional elongation. Thus, the selective transcriptional effects following JQ1 treatment are linked to the inability of JQ1-sensitive genes to sustain compensatory RNAPol2 recruitment to promoters. These observations highlight the role of BET proteins in supporting transcriptional elongation and rationalize how a general suppression of elongation may selectively affects transcription.
Insights
Bromodomain and extraterminal motif (BET) inhibitors like JQ1 selectively impact gene transcription by affecting transcriptional elongation, not Myc downregulation. This reveals BET proteins
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Bromodomain and extraterminal motif (BET) proteins, including BRD4, are key epigenetic regulators.
- BET inhibitors show promise in cancer therapy, often linked to Myc downregulation.
- The precise mechanism of BET inhibitor action, particularly JQ1, requires further elucidation.
Purpose of the Study:
- To investigate the mechanism of action of the BET inhibitor JQ1 in B-cell tumors.
- To determine the relationship between BRD4 eviction, gene transcription, and Myc regulation.
- To identify factors determining JQ1 sensitivity in gene expression.
Main Methods:
- Utilized B-cell tumors as a model system.
- Administered JQ1, a widely used BET inhibitor.
- Analyzed BRD4 chromatin occupancy, gene transcription, and RNA Polymerase II (RNAPol2) recruitment.
Main Results:
- JQ1 induced widespread BRD4 eviction from chromatin but selectively affected a subset of genes.
- JQ1's effects were unlinked to Myc downregulation; sensitive genes were enriched for Myc/E2F targets with high basal transcription.
- JQ1 inhibited transcriptional elongation, with sensitive genes unable to compensate via enhanced RNAPol2 recruitment.
Conclusions:
- BRD4 plays a crucial role in supporting transcriptional elongation, particularly for highly expressed genes.
- Selective gene transcription inhibition by JQ1 arises from the inability of sensitive genes to recruit compensatory RNAPol2.
- BET proteins are critical for maintaining transcriptional elongation, explaining selective effects of elongation inhibitors.
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Regulation of Expression at Multiple Steps
General Transcription Factors
